Status:
COMPLETED
The Impact of Bryophyllum on Preterm Delivery
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Preterm Delivery
Preterm Contractions
Eligibility:
FEMALE
18-50 years
Phase:
PHASE4
Brief Summary
The purpose of this study is whether Bryophyllum is more effective and has less side effects than traditional labor inhibitors in preventing preterm delivery.
Detailed Description
Preterm delivery (delivery before 37 +0 weeks of gestation) is still the leading cause of perinatal mortality and morbidity in the western countries. Due to this fact it is only possible to achieve th...
Eligibility Criteria
Inclusion
- All multiple pregnancies Singleton pregnancies with preterm contractions/cervix \< 25mm, or singleton pregnancies with burdened maternal anamnesis (e.g. prior preterm delivery preterm contractions cerclage).
Exclusion
- Fetal malformations
- Chromosomal anomalies
- Intrauterine growth restriction
Key Trial Info
Start Date :
July 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT00163579
Start Date
July 1 2004
End Date
July 1 2009
Last Update
April 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Obstetrical Unit, Women's University Hospital Basel
Basel, Canton of Basel-City, Switzerland, 4031